@inproceedings{bachet:hal-01632415, TITLE = {{PFOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Final results of the FFCD 1102 phase II trial}}, AUTHOR = {Bachet, J-B. and Lucidarme, O. and Levache, C.B. and Maillard, E. and Raoul, J.L. and Lecomte, T. and Desauw, C. and Brocard, F. and Pernot, S. and Breysacher, G. and Lagasse, J-P. and Di Fiore, F. and Etienne, P.L. and Dupuis, O. and Aleba, A. and Lepage, C. and Taieb, J.}, URL = {https://u-bourgogne.hal.science/hal-01632415}, NOTE = {IF 11.855}, BOOKTITLE = {{the 42nd ESMO Congress (ESMO 2017)}}, ADDRESS = {Madrid, Spain}, SERIES = {Abstract Book of the 42nd ESMO Congress (ESMO 2017) 8--12 September 2017, Madrid, Spain}, VOLUME = {28}, NUMBER = {suppl\_5}, PAGES = {505P}, YEAR = {2017}, MONTH = Sep, DOI = {10.1093/annonc/mdx393.031}, KEYWORDS = {phase 2 clinical trials ; neoplasm metastasis ; rectal carcinoma ; folfirinox}, HAL_ID = {hal-01632415}, HAL_VERSION = {v1}, }